Results 1 - 1 of 1 for neratinib
  1. New treatment approved for HER2-positive breast cancer | NIH MedlinePlus Magazine 
    ... the risk of the cancer returning. The drug, neratinib, is intended for patients with early-stage, HER2- ...
    https://magazine.medlineplus.gov/...-for-her2-positive-breast-cancer - MedlinePlus Magazine